Articaine HCl

CAS No. 23964-57-0

Articaine HCl( Carticaine | HOE 045 | HOE 40045 )

Catalog No. M13691 CAS No. 23964-57-0

Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 29 In Stock
50MG 45 In Stock
100MG 72 In Stock
200MG 109 In Stock
500MG 184 In Stock
1G 276 In Stock

Biological Information

  • Product Name
    Articaine HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
  • Description
    Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Carticaine | HOE 045 | HOE 40045
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    23964-57-0
  • Formula Weight
    320.84
  • Molecular Formula
    C13H21ClN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C(C1=C(NC(C(NCCC)C)=O)C(C)=CS1)OC.[H]Cl
  • Chemical Name
    Methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate Hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oertel R, et al. Clin Pharmacokinet, 1997, 33(6), 417-425.
molnova catalog
related products
  • Lidocaine hydrochlor...

    Lidocaine HCl salt, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo.

  • Transcainide

    Transcainide(R 54718), a new lidocaine analog, is an orally active antiarrhythmic agent.Transcainide blocks the open state of BTX-activated sodium channels in bovine heart and rat skeletal muscle.

  • Flecainide

    A class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias, works by blocking the Nav1.5 sodium channel in the heart.